Oncology

Perjeta (pertuzumab) is now approved for the neoadjuvant treatment of breast cancer.

Understanding the needs of seniors with cancer and helping them to manage the complexities of the treatment process are essential to successful patient engagement and improved clinical outcomes.

FL118 could be effective in treating late stage cancers.

Researchers pinpoint method to reverse cancer cell resistance to chemotherapy.

Researchers find that negatives from daily aspirin outweigh the positives.

Ramucirumab receives third indication of 2014.

The FDA today approved a new indication for ramucirumab for the treatment of metastatic non-small cell lung cancer.

Targeted radiation may also be useful in treating other diseases.

Cimetidine has clinically important benefits in improving colon cancer survival and preclinical evidence shows that this benefit may extend to other types of cancer.

New indication approved for drug to treat patients with HCM, a complication that results from cancer-driven increases in bone resorption.

Agent found to stop growth and spread of prostate cancer with a common chromosomal abnormality.

ASHP today recognized the work of the late Jerod M. Loeb, Ph.D., a tireless patient safety advocate, with the ASHP Board of Directors Award of Honor. Loeb's widow, Sherri, accepted the award during the opening session of ASHP's Midyear Clinical Meeting in Anaheim, CA. Dr. Loeb passed away in 2013 from metastatic prostate cancer.

Primary ADT associated with decreased survival in localized prostate cancer patients.

According to a new study, a CCR5-blocking drug used to treat HIV may also be able to slow prostate cancer metastasis.

Preliminary evidence indicates that new treatment is both safe and effective.

Pfizer's phase 3 study of its anaplastic lymphoma kinase inhibitor, crizotinib, provides good news for patients with ALK-positive advanced non-small cell lung cancer.

The OTC antacid is being investigated for its potenial to combat colon cancer.

Alcohol use is responsible for an estimated 3.5% of cancers in the United States, but affects the risk of developing some cancers more than others.

Concerns still remain, however, and there is a lack of long-term data.

Study examines cellular and molecular mechanisms behind experimental vaccine.

Study finds African Americans and Hispanics significantly less likely to be treated with radiation.

Therapy extended lives of patients by approximately 5 months.

Increased number of patients moving away from breast conservation surgery in early stages of disease.

Oral drug combination effective in treating newly diagnosed multiple myeloma.

A new liquid drug formulation from Teva Pharmaceutical Industries Ltd. will allow some cancer patients to see their therapy administered faster.

Combination therapy eliminates tumors in more than 70% of mice.

Cyclophosphamide found to improve the success of virus therapy in patients with malignant gliomas.

Next generation drug shows anti-cancer activity in 10 of 11 tumor samples during lab tests.

Research may lead to more effective treatments in the future.

Drugs commonly used to treat osteoporosis may benefit patients with diseases like breast cancer.